ROCKVILLE, Md. (AP) - A Rockville company will study the feasibility of a new cancer medicine with the large pharmaceutical company AstraZeneca.
CytImmune Sciences Inc. and AstraZeneca made the announcement on Thursday.
The two companies will work together to see whether they can transmit cancer drugs on extremely small gold particles.
CytImmune works in developing nanomedicine, which uses tiny particles of gold to carry cancer therapies directly to the site of the disease. The company says gold nanoparticles have been used safely since the 1930s to treat patients with rheumatoid arthritis.
Dr. Lawrence Tamarkin, CytImmune's CEO, says the partnership aims to combine CytImmune's nanotechnology research with AstraZeneca's oncology compound to create a cancer therapy that may be widely applicable to solid tumors.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
A Town of Tonawanda restaurant owner has been arrested and charged with strangulation and assault.
A house became engulfed in flames on Route 243, in Rushford, early Wednesday morning.
Law enforcement agencies in El Paso County, Colorado have made an arrest in the hit-and-run death of a western New York native.
Travel advisory for Southern Erie County. Travel ban in North Collins. Travelers advised to avoid I-90 between Exit 57 and Exit 61. More info:
Lakes will remain active on and off through the weekend.
One third of Canadians receive their mail straight to their door but that will soon be changing. Canada Post will phase out their door-to-door delivery over the next five years.